Co-localization of Protein Z, Protein Z-dependent protease inhibitor and coagulation factor X in human colon cancer tissue: Implications for coagulation regulation on tumor cells

Thrombosis Research

Volumn 129, Issue 4, 2012, Pages

  Sierko, Ewa ^a,b   Wojtukiewicz, Marek Z ^a,b   Zimnoch, Lech ^a   Tokajuk, Piotr ^b   Ostrowska Cichocka, Krystyna ^b   Kisiel, Walter ^c  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Regional Comprehensive Cancer Center in Bialystok   (Poland)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Coagulation inhibitor; Colon cancer; Factor X; Protein Z; Protein Z dependent protease inhibitor

Indexed keywords

BLOOD CLOTTING FACTOR 10; FATTY ACID BINDING PROTEIN; FIBRIN; MESSENGER RNA; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; PROTEIN Z DEPENDENT PROTEASE INHIBITOR; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CLOTTING; CANCER CELL; CANCER TISSUE; COLON CANCER; DNA PROBE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MACROPHAGE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; STAINING;

BLOOD COAGULATION FACTORS; BLOOD PROTEINS; COLONIC NEOPLASMS; FACTOR X; HEMOSTASIS; HUMANS; SERPINS; TUMOR CELLS, CULTURED;

EID: 84858337200     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.10.027     Document Type: Article

References (72)

1. A. Trousseau Phlegmasia alba dolens W: Clinique Medicale de l'Hotel-Dieu de Paris 1865 J.B Balliere et Fils Paris 654 712 Wydanie 2, t.3, s
2. R.L. Bick Coagulation abnormalities in malignancy: a review Semin Thromb Hemost 18 1992 353 372
3. A. Falanga, and F.R. Rickles Pathophysiology of the thrombophilic state in the cancer patient Semin Thromb Hemost 25 1999 173 182
4. J. Barnes, V. Patel, and M. Lee Adenocarcinoma of the colon presenting with a Sister Mary Joseph's nodule and Trousseau's syndrome Cutis 56 1995 270 272
5. D. Bergqvist, and B. Lindblad Thromboembolic problems in colorectal cancer surgery Scand J Gastroenterol Suppl 149 1988 74 81
6. H.F.P. Hillen Thrombosis in cancer patients Ann Oncol 11 Suppl. 3 2000 273 276
7. L.H. Iversen, and O.O. Thorlacius-Ussing Relationship of coagulation test abnormalities to tumor burden and postoperative DVT in resected colorectal cancer Thromb Haemost 87 2002 402 408
8. I.I. Modrau, L.L. Iversen, and O. Thorlacius-Ussing Hemostatic alteration in patients with benign and malignant colorectal disease during major abdominal surgery Thromb Res 104 2001 309 315
9. R.L. Bick Coagulation abnormalities in malignancy: a review Semin Thromb Hemost 18 1992 353 372
10. J. Barnes, V. Patel, and M. Lee Adenocarcinoma of the colon presenting with a Sister Mary Joseph's nodule and Trousseau's syndrome Cutis 56 1995 270 272
11. L.H. Iversen, M. Okholm, and O.O. Thorlacius-Ussing Pre- and postoperative state of coagulation and fibrinolysis in plasma of patients with benign and malignant colorectal disease - a preliminary study Thromb Haemost 76 1996 523 527
12. G. Luzzatto, and A.I. Schafer The prethrombotic state in cancer Semin Oncol 17 1990 147 159
13. L.R. Zacharski, M.Z. Wojtukiewicz, V. Costantini, D.L. Ornstein, and V.A. Memoli Pathways of coagulation/fibrinolysis activation in malignancy Semin Thromb Hemost 18 1992 104 116
14. P.G. Cavanaugh, B.F. Sloane, A.S. Bajkowski, J.D. Taylor, and K.V. Honn Purification and characterization of platelet aggregating activity from tumor cells: copurification with procoagulant activity Thromb Res 37 1985 309 326
15. L.V.M. Rao Tissue factor as a tumor procoagulant Cancer Metastasis Rev 11 1992 249 266
16. S.G. Gordon Cancer procoagulant Methods Enzymol 244 1994 568 583
17. K.G. Mann Biochemistry and physiology of blood coagulation Thromb Haemost 82 1999 165 174
18. M.Z. Wojtukiewicz, E. Sierko, and J. Rak Contribution of hemostatic system to angiogenesis in cancer Semin Thromb Hemost 30 2004 5 20
19. M.Z. Wojtukiewicz, E. Sierko, and W. Kisiel The role of hemostatic system inhibitors in malignancy Semin Thromb Hemost 33 2007 621 641
20. N.S. Callendar, N. Varki, and L.V. Rao Immunohistochemical identification of tissue factor in solid tumors Cancer 70 1992 1194 1201
21. E. Sierko, P. Tokajuk, A. Butkiewicz, S. Sulkowski, L. Zimnoch, and M.Z. Wojtukiewicz Ocena ekspresji in loco czynników krzepniȩcia krwi w raku jelita grubego Expression of blood coagulation components expressions in loco in colon cancer Pol Merkur Lekarski 17 2005 176 179
22. C. Gajdusek, S. Carbon, R. Ross, P. Nawroth, and D. Stern Activation of coagulation releases endothelial cell mitogens J Cell Biol 103 1986 419 428
23. A. Papapetropoulus, P. Piccardoni, G. Cirino, M. Bucci, R. Sorrentino, and C. Cicala Hypotension and inflammatory cytokine gene expression triggered by factor Xa-nitric oxide signaling Proc Natl Acad Sci U S A 95 1998 4738 4742
24. P. Schaeffer, A.M. Mares, F. Dol, F. Bono, and J.M. Herbert Coagulation factor Xa induces endothelium - dependent relaxations in rat aorta Circ Res 81 1997 824 828
25. D. Darmoul, V. Gratio, H. Devaud, T. Lehy, and M. Laburthe Aberrant expression and activation of the thrombin receptor protease-activated receptor-1 cell induces cell proliferation and motility in human colon cancer cells Am J Pathol 162 2003 1503 1513
26. X.Q. Yao, F.K. Liu, J.S. Li, X.P. Qi, B. Wu, and H.L. Yin Significance of effector protease receptor-1 expression and its relationship with proliferation and apoptotic index in patients with primary advanced gastric adenocarcinoma World J Gastroenterol 10 2004 1262 1267
27. E. Camerer, W. Huang, and S.R. Coughlin Tissue factor- and factor Xa-dependent activation of protease-activated receptor 2 by factor VIIa Proc Natl Acad Sci U S A 97 2000 5255 5260
28. D. Darmoul, V. Gratio, H. Devaud, and M. Laburthe Protease-activated receptor 2 in colon cancer: trypsin-induced MAPK phosphorylation and cell proliferation are mediated by epidermal growth factor receptor transactivation J Biol Chem 279 2004 20927 20934
29. H.H. Versteeg, C.A. Spek, D.J. Richel, and M.P. Peppelenbosch Coagulation factors VIIa and Xa inhibit apoptosis and anoikis Oncogene 23 2004 410 417
30. M. Riewald, and W. Ruf Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor Proc Natl Acad Sci U S A 98 2001 7742 7747
31. X. Jiang, M.A. Bailly, T.S. Paneti, M. Capello, W.H. Konigsberg, and M.E. Bromberg Formation of tissue factor-factor VIIa-factor Xa complex promotes cellular signaling and migration of human breast cancer cells J Thromb Haemost 2 2004 93 101
32. K.E. Brummel, S.G. Paradis, S. Butenas, and K.G. Mann Thrombin functions during tissue - induced blood coagulation Blood 100 2002 148 152
33. M.Z. Wojtukiewicz, T.G. Tang, E. Ben-Josef, C. Renaud, D.A. Walz, and K.V. Honn Solid tumor cells express functional "tethered ligand" thrombin receptor Cancer Res 55 1995 698 704
34. M.Z. Wojtukiewicz, T.G. Tang, J.J. Ciarelli, K.K. Nelson, D.A. Walz, and C.A. Diglio Thrombin increases the metastatic potential of tumor cell Int J Cancer 54 1993 793 806
35. M.Z. Wojtukiewicz, T.G. Tang, K.K. Nelson, D.A. Walz, C.A. Diglio, and K.V. Honn Thrombin enhances tumor cell adhesive and metastatic properties via increased αIIbβ3 expression on the cell surface Thromb Res 68 1992 233 245
36. N.E. Tsopanoglou, E. Pipili-Synetos, and M.E. Maragoudakis Thrombin promotes angiogenesis by a mechanism independent of fibrin formation Am J Physiol 264 1993 C1302 C1307
37. M.Z. Wojtukiewicz, E. Sierko, P. Klement, and J. Rak The hemostatic system and angiogenesis in malignancy Neoplasia 3 2001 371 384
38. J. Folkman Angiogenesis in cancer, vascular, rheumatoid and other disease Nat Med 1 1995 27 31
39. E. Sierko, M.Z. Wojtukiewicz, L. Zimnoch, and W. Kisiel Tissue factor pathway inhibitor in breast and colon cancer tissue Thromb Haemost 103 2010 198 204
40. C.N. Ellis, H.W. Boggs, G.W. Slagle, P.A. Cole, D.J. Coyle, and W.S. Blakemore Protein C activity, stage of disease, and vascular thrombosis in colon carcinoma Am J Surg 163 1992 78 81
41. E. Sierko, M.Z. Wojtukiewicz, L. Zimnoch, R. Zawadzki, and W. Kisiel Expression of protein C (PC), protein S (PS) and thrombomodulin (TM) in loco in human colorectal cancer Thromb Res 125 2010 e71 e75
42. L.M. Beaulieu, and F.C. Church Activated protein C promotes breast cancer cell migration through interactions with EPCR and PAR-1 Exp Cell Res 313 2007 677 687
43. M. Nguyen, J. Arkell, and C.J. Jackson Activated protein C directly activates human endothelial gelatinase A J Biol Chem 275 2000 9095 9098
44. S. Papadopoulou, A. Scorilas, N. Arnogianaki, B. Papapanayiotou, A. Tzimogiani, and N. Agnantis Expression of gelatinase-A (MMP-2) in human colon cancer and normal colon mucosa Tumor Biol 22 2001 383 389
45. B.P. Patel, S.V. Shah, S.N. Shukla, P.M. Shah, and P.S. Patel Clinical significance of MMP-2 and MMP-9 in patients with oral cancer Head Neck 29 2007 564 572
46. J. Roemisch, E. Gray, J.N. Hoffmann, and C.J. Wiedermann Antithrombin: a new look at the actions of a serine protease inhibitor Blood Coagul Fibrinolysis 13 2002 657 670
47. E. Sierko, R.J. Zawadzki, L. Zimnoch, S. Sulkowski, and M.Z. Wojtukiewicz Ekspresja inhibitorów krzepniȩcia krwi w raku jelita grubego Expression of coagulation system inhibitors in colon cancer Pol Merkur Lekarski 20 2006 462 467
48. H. Honegger, N. Anderson, L.A. Hewitt, and J.L. Tullis Antithrombin III profiles in malignancy, relationship between primary tumors and metastatic sites Thromb Haemost 46 1981 500 503
49. G.J. Broze Jr., and J.P. Miletich Human protein Z J Clin Invest 73 1984 933 938
50. X. Han, R. Fiehler, and G.J. Broze Jr. Characterization of the protein Z-dependent protease inhibitor Blood 96 2000 3049 3055
51. X. Han, R. Fiehler, and G.J. Broze Jr. Isolation of a protein Z-dependent plasma protease inhibitor Proc Natl Acad Sci U S A 95 1998 9250 9255
52. A. Tabatabai, R. Fiehler, and G.J. Broze Jr. Protein Z circulates in plasma in a complex with protein Z-dependent protease inhibitor Thromb Haemost 85 2001 655 660
53. H. Sejima, T. Hayashi, Y. Deyashiki, J. Nishioka, and K. Suzuki Primary structure of vitamin K - dependent human protein Z Biochem Biophys Res Commun 171 1990 661 668
54. A. Ichinose, H. Takeya, E. Espling, S. Iwanaga, W. Kisiel, and E.W. Davie Amino acid sequence of human protein Z, a vitamin K-dependent plasma glycoprotein Biochem Biophys Res Commun 172 1990 1139 1144
55. A.R. Rezaie, J.-S. Bae, C. Manithody, S.H. Qureshi, and L. Yang Protein Z - dependent protease inhibitor binds to the C-terminal domain of protein Z J Biol Chem 283 2008 19922 19926
56. Z. Wei, Y. Yan, R.W. Carrel, and A. Zhou Crystal structure of protein Z-dependent inhibitor complex shows how protein Z functions as a cofactor in the membrane inhibition of factor X Blood 114 Oct 22 2009 3662 3667
57. M. Vasse The protein Z/protein Z-dependent protease inhibitor complex. Systemic or local control of coagulation? Haemostaseologie 31 2011 [epub ehead of print]
58. X. Huang, A.R. Rezaie, G.J. Broze Jr., and S.T. Olson Heparin is a major activator of the anticoagulant serpin, protein Z-dependent protease inhibitor J Biol Chem 286 2011 8740 8751
59. M.Z. Wojtukiewicz, M. Rucińska, L. Zimnoch, J. Jaromin, Z. Piotrowski, and M. Rózańska-Kudelska Expression of prothrombin fragment 1+2 in cancer tissue as an indicator of local activation of blood coagulation Thromb Res 97 2000 335 342
60. S. Hsu, L. Raine, and H. Fanger Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures J Histochem Cytochem 29 1981 577 580
61. W. Remmele, and H.E. Stegner Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue Pathologie 8 1987 138 140
62. E. Sierko, M.Z. Wojtukiewicz, L. Zimnoch, P. Tokajuk, and W. Kisiel Protein Z is present in human breast cancer tissue Int J Hematol 93 2011 681 683
63. E. Sierko, M.Z. Wojtukiewicz, K. Ostrowska-Cichocka, and L. Zimnoch Protein Z-dependent protease inhibitor (ZPI) is present in loco in human breast cancer tissue Thromb Haemost 104 2010 183 185
64. B. Kudryk Specificity of a monoclonal antibody for the NH2-terminal region of fibrin Mol Immunol 21 1984 89 94
65. P. Komminoth, and M. Werner Target and signal amplification: approaches to increase the sensitivity of in situ hybridization Histochem Cell Biol 108 1997 325 333
66. A. Kasprzak, M. Zabel, and J. Wysocki Techniques of molecular biology in morphological diagnosis of DNA and RNA viruses Folia Histochem Cytobiol 39 2001 97 98
67. G. Capurso, S. Lattimore, T. Crnogorac-Jurcevic, F. Panzuto, M. Milione, and V. Bhakta Gene expression profils of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel marker and therapeutic targets Endocr Relat Cancer 13 2006 541 558
68. J. Leya, A. Essaghir, M. Essand, K. Wester, K. Oberg, and T.H. Tötterman Novel markers for enterochromaffin cells and gastrointestinal neuroendocrine carcinomas Mol Pathol 22 2009 261 272
69. M. Vasse PZ, a protein seeking a pathology Thromb Haemost 100 2008 548 556
70. M.Z. Wojtukiewicz, L.R. Zacharski, V.A. Memoli, W. Kisiel, B.J. Kudryk, and S.M. Rousseau Indirect activation of blood coagulation in colon cancer Thromb Haemost 62 1989 1062 1066
71. M. Vasse, C. Denoyelle, C. Corbière, P.Y. Litzler, E. Legrand, and J.P. Vannier Human endothelial cells synthesize protein Z, but not the protein Z-dependent inhibitor Thromb Haemost 95 2006 519 523
72. J. Greten, I. Kreis, B. Liliensiek, J. Amiral, R. Ziegler, and P.P. Nawroth Localization of protein Z in vascular lesions of patients with atherosclerosis Vasa 27 1998 144 148